NCT00373334View on ClinicalTrials.gov

Safety and Efficacy Study of Axid Use in Infants Suffering From Gastroesophageal Reflux Disease (GERD)

PHASE3CompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Gastroesophageal Reflux DiseaseGERDHeartburn
Interventions
DRUG

nizatidine (axid)

nizatidine (axid)

DRUG

nizatidine (axid)

nizatidine (axid)

DRUG

placebo

placebo

Trial Locations (26)

15202

Pittsburgh

32405

Panama City

33603

Tampa

37043

Clarksville

42303

Owensboro

45014

Fairfield

45040

Mason

58103

Fargo

58501

Bismarck

68505

Lincoln

71105

Shreveport

71913

Hot Springs

72205

Little Rock

72211

Little Rock

72401

Jonesboro

76502

Temple

77004

Houston

77495

Missouri City

80112

Centennial

84095

South Jordan

84405

Ogden

Unknown

Searcy

Madiera

Orlando

Tifton

Hershey

Sponsors
All Listed Sponsors
lead

Braintree Laboratories

INDUSTRY